Development of a Low-Profile Dual Hormone Patch Pump with Novel Occlusion Sensor Project Summary: The Specific Aim of this project is to develop a discrete, low-profile, dual hormone drug delivery system using SFC Fluidics enabling microfluidic technologies. A dual ePump® will be developed in which a single ePump body will independently and accurately deliver both insulin and glucagon from two separate reservoirs. Latching micro-valve sets will independently and safely control the delivery of each hormone and a flow confirmation sensor will identify dosing errors from either occlusions or electrical/mechanical failures. Phase I will see the development of an early prototype with control system, and a dosing accuracy of +/- 5% (for nL to ?L dosing volumes) will be targeted. During Phase II, SFC Fluidics will work closely with clinicians and drug formulation, glucose sensor and control algorithm developers to develop a robust and reliable artificial pancreas.
Public Health Relevance Statement: Project narrative: The proposed dual drug delivery system will have the necessary safety features and low dose accuracy to meet the need for insulin and glucagon dual-hormone delivery to type 1 diabetics, including children and adolescents, to greatly improve the quality of life for this significant and growing at-risk group.
Project Terms: Adolescent; Advanced Development; Algorithms; Artificial Pancreas; blood glucose regulation; Child; clinically relevant; Development; Dose; Drug Delivery Systems; Drug Formulations; Equilibrium; Evaluation; Failure; Feedback; Formulation; Glucagon; glucose sensor; Government; Guidelines; Hormone use; Hormones; improved; In Vitro; in vivo; Insulin; Measurement; Measures; Mechanics; meetings; meter; Microfluidics; novel; Persons; Pharmaceutical Preparations; Phase; Protocols documentation; prototype; Pump; Quality of life; Randomized; Reading; Reporting; Risk; Safety; sensor; Side; Syringes; System; Technology; Testing; Time; type I diabetic; Water; Work